APA (7th ed.) Citation

Dösch, A., Gleißner, C. A., Akhavanpoor, M., Rohde, D., Hakimi, M., Katus, H., & Erbel, C. (2014). Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions. Drug design, development and therapy, 8, . https://doi.org/10.2147/DDDT.S59594

Chicago Style (17th ed.) Citation

Dösch, Andreas, Christian A. Gleißner, Mohammadreza Akhavanpoor, David Rohde, Maani Hakimi, Hugo Katus, and Christian Erbel. "Inhibition of B7-1 (CD80) by RhuDex® Reduces Lipopolysaccharide-mediated Inflammation in Human Atherosclerotic Lesions." Drug Design, Development and Therapy 8 (2014). https://doi.org/10.2147/DDDT.S59594.

MLA (9th ed.) Citation

Dösch, Andreas, et al. "Inhibition of B7-1 (CD80) by RhuDex® Reduces Lipopolysaccharide-mediated Inflammation in Human Atherosclerotic Lesions." Drug Design, Development and Therapy, vol. 8, 2014, https://doi.org/10.2147/DDDT.S59594.